Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Hogan

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Nature Genetics|August 7, 2025
Analysis of individual patient pathway coordination in a cross-species single-cell kidney atlasKonstantin A Klötzer, Amin Abedini, Shen Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 2019
Heavy Chain Fibrillary Glomerulonephritis: A Case ReportSamih H Nasr, Christophe Sirac, Frank Bridoux, et al.
Kidney International|November 2, 2025
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cellsBurcin Altun, Gexin Zhao, Baomei Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 29, 2020
The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: An Interim Analysis of the TRIDENT StudyJonathan J Hogan, Jonathan G Owen, Shira J Blady, et al.
Kidney International|February 1, 2020
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell cloneSamih H Nasr, Christopher P Larsen, Christophe Sirac, et al.
Kidney International Reports|June 11, 2020
Persistent Disease Activity in Patients With Long-Standing Glomerular DiseaseElisa Delbarba, Maddalena Marasa, Pietro A Canetta, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
Kidney International|May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular diseaseSimon A Carter, Liz Lightstone, Daniel Cattran, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Nature Genetics|August 7, 2025
Analysis of individual patient pathway coordination in a cross-species single-cell kidney atlasKonstantin A Klötzer, Amin Abedini, Shen Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 2019
Heavy Chain Fibrillary Glomerulonephritis: A Case ReportSamih H Nasr, Christophe Sirac, Frank Bridoux, et al.
Kidney International|November 2, 2025
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cellsBurcin Altun, Gexin Zhao, Baomei Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 29, 2020
The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: An Interim Analysis of the TRIDENT StudyJonathan J Hogan, Jonathan G Owen, Shira J Blady, et al.
Kidney International|February 1, 2020
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell cloneSamih H Nasr, Christopher P Larsen, Christophe Sirac, et al.
Kidney International Reports|June 11, 2020
Persistent Disease Activity in Patients With Long-Standing Glomerular DiseaseElisa Delbarba, Maddalena Marasa, Pietro A Canetta, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
Kidney International|May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular diseaseSimon A Carter, Liz Lightstone, Daniel Cattran, et al.
Pageof 6